Paragon Biosciences has a masterful CEO at the helm. Jeff Aronin has held the position since 2010 and serves as its Chairman as well (https://about.me/jeffaronin). The company develops healthcare companies around the world. Several firms backed by Paragon include Harmony Biosciences and Castle Creek Pharmaceuticals.
Jeff Aronin brings a lot of experience to the table having been in numerous high-profile positions throughout his life. His business forte includes finance, brand marketing, and business development. Aronin also has a great deal of experience working with corporate initiatives that include transactions involving acquisitions and mergers.
Aronin has two decades of experience helping develop companies in the competitive biotech vertical. These are companies that are striving to find medical solutions and treatments for rare diseases. His track record for creating new treatment drugs has distinguished him as one of the most influential and impactful leaders in bioscience sectors.
He also shows an immense talent for creating talented and capable teams of scientists. As such, he has a proven track record in his field for bringing new medicines to market. Many of the patients who benefit are those with overlooked lives as being incurable or beyond medical help. His efforts have made a definite impact in the medical world, and his teams have successfully brought to market 13 drug approvals by the FDA. This success rate trumps most of his health sector peers.
Perhaps, the world will regard Aronin greatest accomplishments as having mentored many in his field. Paragon Biosciences begins its research by trying to fully understand each patient’s needs to under the science that causes the disease. This, in a nutshell, is the business model that drives the company’s success. Shockingly, there are more than 6,000 diseases without an available treatment. The company’s goal is to drastically reduce that number.